How does CAG repeat expansion in the HTT gene lead to neurodegeneration in Huntington disease?
The corpus documents describe the polyglutamine-expansion mechanism and downstream GABAergic neuron loss at a fairly high level; a fully mechanistic answer (e.g. specific proteostasis/autophagy pathway details) would need documents outside this 24-document v0 sample — flagged as a partial-coverage task, not a full-mechanism one.
Generation outcome
Gold documents (2)
- Poly ADP-ribose signaling is dysregulated in Huntington disease.
- Huntington's Disease: A Report of an Interesting Case and Literature Review.
Retrieved documents (6)
- CSPα in neurodegenerative diseases.pubmed:36466613
- Poly ADP-ribose signaling is dysregulated in Huntington disease.pubmed:39331414gold
- Huntington's Disease: A Report of an Interesting Case and Literature Review.pubmed:38567236gold
- Translating HDAC inhibitors in Friedreich's ataxia.pubmed:28392990
- Friedreich's ataxia: new insights.pubmed:37698160
- Autophagy and Polyglutamine Disease.pubmed:32671744
Generated claims (5)
CAG repeat expansion in the HTT gene causes an expanded polyglutamine tract in the HTT protein.
The age of onset and severity of Huntington disease are related to the length of the polyglutamine fragment.
CAG repeat expansion in the HTT gene affects DNA repair pathways, particularly the PARP pathway.
Mutant HTT protein impairs the PAR response and contributes to neuronal dysfunction.
CAG repeat expansion in the HTT gene results in the progressive deterioration of GABAergic neurons in the basal ganglia.